台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國邑*

(6875)
  • 股價
    56.2
  • 漲跌
    ▲1.9
  • 漲幅
    +3.50%
  • 成交量
    148
  • 產業
    上櫃 生技醫療類股
  • 8人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
國邑* (6875)籌碼相關-元大-八德 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-八德 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/141451.8800.0053.001413610.25%
2025/01/13352.0000.0051.4031402.13%
2025/01/091454.1300.0054.50141449.71%
2025/01/032154.0700.0053.702115313.72%
2025/01/02453.9500.0053.9041602.48%
2024/12/311852.93054.0052.90181919.38%
2024/12/19054.0000.0053.2002100.01%
2024/12/1300.00055.3554.200216-0.02%
2024/12/0500.00058.1058.100226-0.02%
2024/11/2200.000.159.0056.90-0.1249-0.02%
2024/11/2000.000.160.1059.20-0.1270-0.02%
2024/11/1400.000.264.0863.00-0.2282-0.07%
2024/11/1300.000.263.3063.20-0.2282-0.07%
2024/10/29061.0000.0061.0003080.01%
2024/10/28062.0000.0061.6003130.01%
2024/10/25063.0000.0062.5003130.01%
2024/10/21061.7000.0063.4003180.01%
2024/10/180.163.3700.0062.000.13220.02%
2024/10/17063.3000.0063.4003220.01%
2024/10/15064.4000.0063.2003260.01%
2024/10/14063.2000.0064.6003280.01%
2024/10/11064.8000.0064.8003280.01%
2024/10/08066.1100.0066.0003280.01%
2024/10/07373.001669.3468.00-13324-4.00%
2024/08/0600.002349.2549.95-23278-8.27%
2024/08/050.354.2700.0053.600.32720.11%
2024/07/30258.05557.7058.30-3267-1.12%
2024/07/26157.3000.0059.5012790.36%
2024/07/22160.7000.0060.8012880.35%
2024/07/190.165.0000.0064.000.12940.03%
2024/07/18166.5000.0066.1012910.34%
2024/07/12164.8000.0064.8013060.33%
2024/07/110.165.3000.0065.200.13090.03%
2024/07/10165.1000.0065.2013170.31%
2024/07/09266.1500.0065.8023290.61%
2024/07/08167.6000.0067.2013330.30%
2024/07/04168.4000.0068.4013370.30%
2024/07/03168.1000.0068.8013410.29%
2024/07/02169.1000.0069.3013440.29%
2024/07/01070.8000.0070.1003500.01%
2024/06/28071.4000.0071.1003590.01%
2024/06/2700.000.173.7374.00-0.1380-0.02%
2024/06/2400.00072.0070.5004520.00%
2024/06/19169.4000.0069.0014630.22%
2024/06/1800.000.270.1069.60-0.2466-0.05%
2024/06/17170.2000.0070.1014720.21%
2024/06/13169.7000.0070.1014800.21%
2024/06/11570.5600.0070.0055001.00%
2024/06/06274.6500.0073.7025280.38%
2024/06/05576.6000.0077.4055440.92%
2024/05/312976.5600.0076.40295964.86%
2024/05/302276.4200.0076.50226233.53%
2024/05/210.178.6500.0077.000.18440.01%
2024/05/200.181.900.281.0182.00-0.1849-0.02%
2024/05/170.276.2500.0075.900.28630.02%
2024/05/1600.00171.5071.50-1892-0.11%
2024/05/14170.0000.0073.0019590.10%
2024/05/0900.0056.968.2668.20-56.9964-5.89%
2024/05/0800.001367.7069.30-13971-1.34%
2024/05/070.269.001970.0167.70-18.8973-1.93%
2024/05/03172.7000.0071.8019670.10%
2024/05/02171.7000.0072.7019630.10%
2024/04/30274.7000.0073.5029610.21%
2024/04/290.170.4000.0070.900.19450.01%
2024/04/260.364.6300.0064.500.39370.03%
2024/04/1800.00369.8769.00-3909-0.33%
2024/04/1600.00171.0071.70-1905-0.11%
2024/04/12179.8000.0079.8018800.11%
2024/04/11080.8000.0080.7008720.00%
2024/04/09080.75080.4080.2008630.00%
2024/04/03082.4000.0082.9008530.00%
2024/04/02083.9000.0084.1008470.00%
2024/04/010.183.7000.0086.900.18350.01%
2024/03/29179.9000.0080.0018130.12%
國邑*吸入新藥完成澳洲一期臨床 預計年底完成與美國FDA Pre-IND會議Anue鉅亨-2024/10/23
國邑* 相關文章
國邑* 相關影音